← Назад к работе
Работы, на которые ссылается эта работа
Работ: 213
Работа: Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett +37
Статья2017Цитирований: 2ABIDisruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons +35
Статья2018Цитирований: 2ABIGene Editing and Genotoxicity: Targeting the Off-Targets
Georges Blattner, Alessia Cavazza, Adrian J. Thrasher +1
Обзорная статья2020Цитирований: 2ABIEndowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
Sumin Jo, Shipra Das, Alan F. Williams +19
Статья2022Цитирований: 2ABINanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines
Eugenia D. Namiot, Aleksandr V. Sokolov, Vladimir N. Chubarev +2
Обзорная статья2023Цитирований: 2ABICurrent Strategies for Exosome Cargo Loading and Targeting Delivery
Haifeng Zeng, Shaoshen Guo, Xuancheng Ren +3
Обзорная статья2023Цитирований: 2ABIThe paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods
Yekta Metanat, Patrik Viktor, Ayesha Amajd +10
Обзорная статья2024Цитирований: 2ABIFocusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy
Siheng Zhang, Linglong Peng, Yifei Chen +2
Обзорная статья2024Цитирований: 2ABICD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>
Karlo Perica, Nayan Jain, Michael Scordo +23
Статья2025Цитирований: 2ABI